↓ Skip to main content

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
2 patents

Citations

dimensions_citation
120 Dimensions

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways
Published in
Pharmacogenomics and Personalized Medicine, August 2014
DOI 10.2147/pgpm.s52762
Pubmed ID
Authors

Sarah R Hosford, Todd W Miller

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Mexico 1 <1%
Egypt 1 <1%
Unknown 134 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 27 20%
Student > Master 21 15%
Researcher 17 12%
Student > Bachelor 15 11%
Student > Doctoral Student 8 6%
Other 25 18%
Unknown 24 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 20%
Medicine and Dentistry 27 20%
Agricultural and Biological Sciences 27 20%
Pharmacology, Toxicology and Pharmaceutical Science 13 9%
Chemistry 3 2%
Other 11 8%
Unknown 28 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2023.
All research outputs
#2,377,232
of 25,748,735 outputs
Outputs from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Outputs of similar age
#23,014
of 240,939 outputs
Outputs of similar age from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,939 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them